Cargando…
An open source automated tumor infiltrating lymphocyte algorithm for prognosis in melanoma
Assessment of tumor infiltrating lymphocytes (TILs) as a prognostic variable in melanoma has not seen broad adoption due to lack of standardization. Automation could represent a solution. Here, using open source software, we build an algorithm for image-based automated assessment of TILs on hematoxy...
Autores principales: | , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6884485/ https://www.ncbi.nlm.nih.gov/pubmed/31784511 http://dx.doi.org/10.1038/s41467-019-13043-2 |
_version_ | 1783474558006722560 |
---|---|
author | Acs, Balazs Ahmed, Fahad Shabbir Gupta, Swati Wong, Pok Fai Gartrell, Robyn D. Sarin Pradhan, Jaya Rizk, Emanuelle M. Gould Rothberg, Bonnie Saenger, Yvonne M. Rimm, David L. |
author_facet | Acs, Balazs Ahmed, Fahad Shabbir Gupta, Swati Wong, Pok Fai Gartrell, Robyn D. Sarin Pradhan, Jaya Rizk, Emanuelle M. Gould Rothberg, Bonnie Saenger, Yvonne M. Rimm, David L. |
author_sort | Acs, Balazs |
collection | PubMed |
description | Assessment of tumor infiltrating lymphocytes (TILs) as a prognostic variable in melanoma has not seen broad adoption due to lack of standardization. Automation could represent a solution. Here, using open source software, we build an algorithm for image-based automated assessment of TILs on hematoxylin-eosin stained sections in melanoma. Using a retrospective collection of 641 melanoma patients comprising four independent cohorts; one training set (N = 227) and three validation cohorts (N = 137, N = 201, N = 76) from 2 institutions, we show that the automated TIL scoring algorithm separates patients into favorable and poor prognosis cohorts, where higher TILs scores were associated with favorable prognosis. In multivariable analyses, automated TIL scores show an independent association with disease-specific overall survival. Therefore, the open source, automated TIL scoring is an independent prognostic marker in melanoma. With further study, we believe that this algorithm could be useful to define a subset of patients that could potentially be spared immunotherapy. |
format | Online Article Text |
id | pubmed-6884485 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | Nature Publishing Group UK |
record_format | MEDLINE/PubMed |
spelling | pubmed-68844852019-12-03 An open source automated tumor infiltrating lymphocyte algorithm for prognosis in melanoma Acs, Balazs Ahmed, Fahad Shabbir Gupta, Swati Wong, Pok Fai Gartrell, Robyn D. Sarin Pradhan, Jaya Rizk, Emanuelle M. Gould Rothberg, Bonnie Saenger, Yvonne M. Rimm, David L. Nat Commun Article Assessment of tumor infiltrating lymphocytes (TILs) as a prognostic variable in melanoma has not seen broad adoption due to lack of standardization. Automation could represent a solution. Here, using open source software, we build an algorithm for image-based automated assessment of TILs on hematoxylin-eosin stained sections in melanoma. Using a retrospective collection of 641 melanoma patients comprising four independent cohorts; one training set (N = 227) and three validation cohorts (N = 137, N = 201, N = 76) from 2 institutions, we show that the automated TIL scoring algorithm separates patients into favorable and poor prognosis cohorts, where higher TILs scores were associated with favorable prognosis. In multivariable analyses, automated TIL scores show an independent association with disease-specific overall survival. Therefore, the open source, automated TIL scoring is an independent prognostic marker in melanoma. With further study, we believe that this algorithm could be useful to define a subset of patients that could potentially be spared immunotherapy. Nature Publishing Group UK 2019-11-29 /pmc/articles/PMC6884485/ /pubmed/31784511 http://dx.doi.org/10.1038/s41467-019-13043-2 Text en © The Author(s) 2019 Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/. |
spellingShingle | Article Acs, Balazs Ahmed, Fahad Shabbir Gupta, Swati Wong, Pok Fai Gartrell, Robyn D. Sarin Pradhan, Jaya Rizk, Emanuelle M. Gould Rothberg, Bonnie Saenger, Yvonne M. Rimm, David L. An open source automated tumor infiltrating lymphocyte algorithm for prognosis in melanoma |
title | An open source automated tumor infiltrating lymphocyte algorithm for prognosis in melanoma |
title_full | An open source automated tumor infiltrating lymphocyte algorithm for prognosis in melanoma |
title_fullStr | An open source automated tumor infiltrating lymphocyte algorithm for prognosis in melanoma |
title_full_unstemmed | An open source automated tumor infiltrating lymphocyte algorithm for prognosis in melanoma |
title_short | An open source automated tumor infiltrating lymphocyte algorithm for prognosis in melanoma |
title_sort | open source automated tumor infiltrating lymphocyte algorithm for prognosis in melanoma |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6884485/ https://www.ncbi.nlm.nih.gov/pubmed/31784511 http://dx.doi.org/10.1038/s41467-019-13043-2 |
work_keys_str_mv | AT acsbalazs anopensourceautomatedtumorinfiltratinglymphocytealgorithmforprognosisinmelanoma AT ahmedfahadshabbir anopensourceautomatedtumorinfiltratinglymphocytealgorithmforprognosisinmelanoma AT guptaswati anopensourceautomatedtumorinfiltratinglymphocytealgorithmforprognosisinmelanoma AT wongpokfai anopensourceautomatedtumorinfiltratinglymphocytealgorithmforprognosisinmelanoma AT gartrellrobynd anopensourceautomatedtumorinfiltratinglymphocytealgorithmforprognosisinmelanoma AT sarinpradhanjaya anopensourceautomatedtumorinfiltratinglymphocytealgorithmforprognosisinmelanoma AT rizkemanuellem anopensourceautomatedtumorinfiltratinglymphocytealgorithmforprognosisinmelanoma AT gouldrothbergbonnie anopensourceautomatedtumorinfiltratinglymphocytealgorithmforprognosisinmelanoma AT saengeryvonnem anopensourceautomatedtumorinfiltratinglymphocytealgorithmforprognosisinmelanoma AT rimmdavidl anopensourceautomatedtumorinfiltratinglymphocytealgorithmforprognosisinmelanoma AT acsbalazs opensourceautomatedtumorinfiltratinglymphocytealgorithmforprognosisinmelanoma AT ahmedfahadshabbir opensourceautomatedtumorinfiltratinglymphocytealgorithmforprognosisinmelanoma AT guptaswati opensourceautomatedtumorinfiltratinglymphocytealgorithmforprognosisinmelanoma AT wongpokfai opensourceautomatedtumorinfiltratinglymphocytealgorithmforprognosisinmelanoma AT gartrellrobynd opensourceautomatedtumorinfiltratinglymphocytealgorithmforprognosisinmelanoma AT sarinpradhanjaya opensourceautomatedtumorinfiltratinglymphocytealgorithmforprognosisinmelanoma AT rizkemanuellem opensourceautomatedtumorinfiltratinglymphocytealgorithmforprognosisinmelanoma AT gouldrothbergbonnie opensourceautomatedtumorinfiltratinglymphocytealgorithmforprognosisinmelanoma AT saengeryvonnem opensourceautomatedtumorinfiltratinglymphocytealgorithmforprognosisinmelanoma AT rimmdavidl opensourceautomatedtumorinfiltratinglymphocytealgorithmforprognosisinmelanoma |